← Open Payments lookup

STEPHEN LOUGHRAN: Open Payments

NPI 1801865308 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,184 in 46 payments from 18 companies in 2025. Trend: 2023 $1,469 · 2024 $1,353 · 2025 $1,184

Food & beverage: $1,098Education: $87
CompanyPaymentsAmount
Amgen Inc.3$158
Merck Sharp & Dohme LLC6$157
Boehringer Ingelheim Pharmaceuticals, Inc.8$151
Regeneron Healthcare Solutions, Inc.3$132
Verona Pharma, Inc.4$102
ABBVIE INC.4$88
Lilly USA, LLC3$76
Takeda Pharmaceuticals U.S.A., Inc.2$48
AstraZeneca Pharmaceuticals LP2$39
Novo Nordisk Inc2$38

Products named: WINREVAIR, DUPIXENT, EVENITY, Ohtuvayre, VRAYLAR, JARDIANCE, OFEV, GLASSIA.

Industry payments across CA — which companies pay providers there.